398 related articles for article (PubMed ID: 15323610)
21. [Applications and safety of modern antidepressants in patients with liver diseases].
Dubarek W; Kucia K
Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
[TBL] [Abstract][Full Text] [Related]
22. Mirtazapine for alcohol dependence: a case report.
Crockford DN; White WD
J Clin Psychiatry; 2005 Apr; 66(4):540. PubMed ID: 15816801
[No Abstract] [Full Text] [Related]
23. Care of depressed patients with anxiety symptoms.
Nutt DJ
J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
[TBL] [Abstract][Full Text] [Related]
24. Serotonin syndrome with mirtazapine-fluoxetine combination.
Benazzi F
Int J Geriatr Psychiatry; 1998 Jul; 13(7):495-6. PubMed ID: 9695042
[No Abstract] [Full Text] [Related]
25. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
Hong CJ; Hu WH; Chen CC; Hsiao CC; Tsai SJ; Ruwe FJ
J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
[TBL] [Abstract][Full Text] [Related]
26. Antagonism of selective serotonin reuptake inhibitor-induced nausea by mirtazapine.
Pedersen L; Klysner R
Int Clin Psychopharmacol; 1997 Jan; 12(1):59-60. PubMed ID: 9179636
[No Abstract] [Full Text] [Related]
27. Successful treatment of anorexia with a combination of high-dose olanzapine, fluoxetine and mirtazapine.
Fountoulakis KN; Iacovides A; Siamouli M; Koumaris V; Kaprinis GS
Int J Clin Pharmacol Ther; 2006 Sep; 44(9):452-3. PubMed ID: 16995335
[No Abstract] [Full Text] [Related]
28. Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial.
Michelson D; Kociban K; Tamura R; Morrison MF
J Psychiatr Res; 2002; 36(3):147-52. PubMed ID: 11886692
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
Kim SW; Shin IS; Kim JM; Kim YC; Kim KS; Kim KM; Yang SJ; Yoon JS
Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
Fava M; Dunner DL; Greist JH; Preskorn SH; Trivedi MH; Zajecka J; Cohen M
J Clin Psychiatry; 2001 Jun; 62(6):413-20. PubMed ID: 11465517
[TBL] [Abstract][Full Text] [Related]
31. Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.
Wingen M; Bothmer J; Langer S; Ramaekers JG
J Clin Psychiatry; 2005 Apr; 66(4):436-43. PubMed ID: 15816785
[TBL] [Abstract][Full Text] [Related]
32. Mirtazapine-associated hyponatremia presenting as delirium.
Ghosh A; Hegde A; Grover S
Indian J Pharmacol; 2014; 46(4):448-9. PubMed ID: 25097290
[TBL] [Abstract][Full Text] [Related]
33. Antidepressants for insomnia in adults.
Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
[TBL] [Abstract][Full Text] [Related]
34. Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens.
Radhakishun FS; van den Bos J; van der Heijden BC; Roes KC; O'Hanlon JF
J Clin Psychopharmacol; 2000 Oct; 20(5):531-7. PubMed ID: 11001237
[TBL] [Abstract][Full Text] [Related]
35. Dystonia induced by mirtazapine.
Lu R; Hurley AD; Gourley M
J Clin Psychiatry; 2002 May; 63(5):452-3. PubMed ID: 12019672
[No Abstract] [Full Text] [Related]
36. Urinary incontinence with mirtazapine.
Kunwar A; Virk S; Masand PS
J Clin Psychiatry; 2002 May; 63(5):454. PubMed ID: 12019674
[No Abstract] [Full Text] [Related]
37. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Bateman DN; Chick J; Good AM; Kelly CA; Masterton G
Eur J Clin Pharmacol; 2004 May; 60(3):221-4. PubMed ID: 15083251
[TBL] [Abstract][Full Text] [Related]
38. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
[TBL] [Abstract][Full Text] [Related]
39. Genetics in pharmacokinetics?
Hartter S
Am J Psychiatry; 2004 Jul; 161(7):1308-9; author reply 1309. PubMed ID: 15229072
[No Abstract] [Full Text] [Related]
40. Mirtazapine: clinical overview.
Gorman JM
J Clin Psychiatry; 1999; 60 Suppl 17():9-13; discussion 46-8. PubMed ID: 10446735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
